Figure 3.
Effects of intranasal natural products on survival rate. Suffixes denote distinct experimental conditions within the same study: Theisen 2012a (4 LD50) and 2012b (1 LD50); Zhang 2019a (PR8) and 2019b (FM1); Joo 2022 (1)a (ESE), (1)b (PGG), and (1)c (GE); Yang 2023a (initiated at 24 h post-infection) and 2023b (initiated at 48 h post-infection); Kim 2015a (PR8) and 2015b (CA04).
